Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03270462Phase 4Completed
Phase 4, open-label, single-arm trial of tacrolimus in kidney transplantation, sponsored by University of Colorado Denver. Primary endpoint: Quality of Life at 6 months. Started Dec 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03270462.